How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Lanqin Market
- By Product Category: Herbal Extracts, Traditional Chinese Medicine (TCM) Ingredients, Natural Health Supplements, Medicinal Mushrooms, Essential Oils
- By End User: Pharmaceutical Manufacturers, Health Supplement Producers, Cosmetic Industry, Traditional Medicine Practitioners, Research Institutions
- By Form: Dried Herbs, Powdered Extracts, Liquid Extracts, Capsules/Tablets, Tinctures
- By Distribution Channel: Wholesale Distributors, Online Retailers, Pharmacies, Direct Sales to Manufacturers, Specialty Health Stores
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Herbal Extracts leads By Product Category at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 3 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 253 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 3 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Lanqin Market report
A complete, evidence-based study - 11 chapters and 106 sections covering market size, segmentation across 4 axes, regional analysis and 3 company profiles, forecast to 2033.
Segmentation covered
Product Category 5
End User 5
Form 5
Distribution Channel 5
Companies profiled
Yangtze River Pharmaceutical Group
Sailing Pharmaceutical Technology Group
Conba Group
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
3 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Yangtze River Pharmaceutical Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sailing Pharmaceutical Technology Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Conba Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.166 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,820M by 2033 · 11.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Herbal Extracts51.8
- Traditional Chinese Medicine (TCM) Ingredients14.2
- Natural Health Supplements16.7
- Medicinal Mushrooms7.9
- Essential Oils9.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,522M → $3,255M · 10.0%
Europe$1,061M → $2,537M · 11.5%
Asia Pacific$968.4M → $2,460M · 12.4%
Latin America$599.5M → $1,477M · 11.9%
Middle East and Africa$461.2M → $1,060M · 11.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.212026
11.222027
11.232028
11.242029
11.262030
11.262031
11.272032
11.282033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Yangtze River Pharmaceutical Group23.3
- Sailing Pharmaceutical Technology Group25.3
- Conba Group23.5
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Category19.9%
End User27.0%
Form32.1%
Distribution Channel21.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.2
- Europe23.5
- Asia Pacific22.8
- Latin America13.7
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
5 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Yangtze River Pharmaceutical Group | 79 | 89 | 90 | 73 | 97 | 80 | 85 |
| Sailing Pharmaceutical Technology Group | 69 | 68 | 91 | 68 | 83 | 72 | 75 |
| Conba Group | 78 | 66 | 77 | 80 | 77 | 85 | 77 |
| Market Leader Co | 80 | 68 | 63 | 66 | 79 | 68 | 71 |
| Global Peer Inc | 52 | 66 | 69 | 66 | 67 | 73 | 66 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Yangtze River Pharmaceutical Group
- Sailing Pharmaceutical Technology Group
- Conba Group
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Yangtze River Pharmaceutical Group | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Sailing Pharmaceutical Technology Group | − | ◐ | ◐ | ◐ | ✓ | ✓ |
| Conba Group | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Market Leader Co | ✓ | − | − | ◐ | ✓ | ◐ |
| Global Peer Inc | − | ◐ | ✓ | ◐ | ◐ | ✓ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Yangtze River Pharmaceutical Group85
2Conba Group77
3Sailing Pharmaceutical Technology Group75
4Market Leader Co71
5Global Peer Inc66
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Yangtze River Pharmaceutical Group
Challenger3
Strong scale, closing on the leaders.
Sailing Pharmaceutical Technology GroupConba GroupMarket Leader Co
Contender1
Focused players with pockets of strength.
Global Peer Inc
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Category in North America, then scale across Lanqin Market — a $276M beachhead inside a $4.27B market.
Beachhead (SOM)$276Mobtainable near-term
Serviceable (SAM)$1.70Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Herbal Extracts
Best fit — highest urgency & budget in Product Category.
Economic buyer80 fit
Traditional Chinese Medicine (TCM) Ingredients
Strong fit — clear ROI and a fast path to value.
End user67 fit
Natural Health Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Category in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Category leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Lanqin Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified21%
Evaluation11%
Closed-won6%
$21.6KCAC
$78KLTV
3.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Lanqin Market is a high-growth opportunity — $6.92B by 2033, compounding at 11.7%.
TAM · 2025$2.86Btoday
TAM · 2033$6.92Bforecast
CAGR11.7%2027–2033
Cumulative$41.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.92BTotal addressable market
SAM$2.61BServiceable available market
SOM$574MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.7% CAGR
Demand compounds through 2033, outpacing GDP across Product Category.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Category moving from early to mainstream — durable secular demand.
Consolidation upside
3+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.92BLarge & growingTAM by 2033 at 11.7% CAGR
$2.61BServiceable nowreachable with today’s model
$574MBeachhead winobtainable near-term share
3+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.40BBear7.6% CAGR
$6.92BBase11.7% CAGR
$8.86BBull15.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Lanqin Market — a $1.91B market by 2033. Plan: grow share from 8.7% to 17.3%.
Market size · 2033$1.91Btotal addressable
Market CAGR7.7%2027–2033
Target share17.3%from 8.7% today
Revenue ambition$331Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.7% | 17.3% | On track |
| Revenue | $173M | $331M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 36.1% | 41.9% | Ahead |
| Customer retention | 84.8% | 93.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Category
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Category share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $43M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Category leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Lanqin Market conversation — a $5.33B market you can size, segment and defend in minutes.
Market size · 2033$5.33Btotal opportunity
Growth8.0%CAGR to 2033
Addressable buyers1,104+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Category
Goal Grow share in Product Category
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 4 mopayback period
$61K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
3+players profiled in this market
Coverage includes
Yangtze River Pharmaceutical GroupSailing Pharmaceutical Technology GroupConba Group
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Lanqin Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Lanqin Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Lanosterol Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportLanolin Wax Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportLanolin Cholesterol Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportLanolin Acid Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportLanoceric Acid Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportLan Isolators Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportLangasite Market
Market size, share, segmentation and regional forecast.
$876M market · 2025 base year
View reportLanding Mats Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportLamp Filament Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportL-Ammonium Lactate Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportLamination Burn Off Furnaces Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportLamination Adhesives for Flexible Packaging Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.